Glenn R. Larsen is Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 36,094 shares of ANIK, which is worth approximately $620,094. The most recent transaction as insider was on Jul 09, 2024, when has been sold 5,771 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.1K
0% 3M change
19.03% 12M change
Total Value Held $620,094

Glenn R. Larsen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 09 2024
BUY
Grant, award, or other acquisition
-
5,771 Added 13.78%
36,094 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
6,500 Added 17.65%
30,323 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
7,954 Added 25.03%
23,823 Common Stock
Jun 16 2021
BUY
Grant, award, or other acquisition
-
4,172 Added 20.82%
15,869 Common Stock
GRL

Glenn R. Larsen

Director
Bedford, MA

Track Institutional and Insider Activities on ANIK

Follow Anika Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

News

Receive news related to Anika Therapeutics, Inc.

Track Activities on ANIK